Plasma interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist levels in pre-eclampsia

被引:22
作者
Kimya, Y
Akdis, C
Cengiz, C
Ozan, H
Tatlikazan, S
Uncu, G
Sengul, F
机构
[1] ULUDAG UNIV,FAC MED,DEPT OBSTET & GYNECOL,BURSA,TURKEY
[2] ULUDAG UNIV,FAC MED,DEPT MICROBIOL,BURSA,TURKEY
来源
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 1997年 / 73卷 / 01期
关键词
pre-eclampsia; interleukin-1; alpha; beta; interleukin-1 receptor antagonist;
D O I
10.1016/S0301-2115(97)02698-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The values of plasma interleukin-1 alpha (IL-1 alpha), interleukin-1 beta (IL-1 beta) and interleukin-l receptor antagonist (IL-1ra) levels were evaluated as the markers of pre-eclampsia in 35 serial plasma samples from ten pregnant women who subsequently developed pre-eclampsia and in 74 plasma samples from 20 uncomplicated pregnancies, retrospectively. No correlation was found between plasma IL-1 alpha, IL-1 beta and IL-1ra levels, liver and renal function tests, thrombocyte and white blood cell counts, proteinuria, measured in all systolic and diastolic blood pressures and gestational weeks. Almost equal levels of IL-1 alpha and IL-1 beta were corresponding groups, but these were too few in number to statistically analyze. IL-1ra values were higher in the pre-eclampsia group than in the uncomplicated pregnancy group, at 20-25 and 31-35 gestational weeks significantly and 26-30 gestational weeks insignificantly and showed an increase during labor in both groups. It was found to have 58% positive predictivity, 100% negative predictivity, 50% specificity and 100% sensitivity at gestational weeks 20-25. According to these results, IL-1ra seems to be considered for its high negative predictivity in the exclusion of the probability of pre-eclampsia development during antenatal visits, but its plasma level is not correlated with the severity of the disease. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 20 条
[1]   LIPOPOLYSACCHARIDE INDUCES HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-1 PRODUCTION IN THE SAME CELL [J].
ANDERSSON, J ;
BJORK, L ;
DINARELLO, CA ;
TOWBIN, H ;
ANDERSSON, U .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (10) :2617-2623
[2]  
[Anonymous], 1992, Clin Obstet Gynecol, V35, P315
[3]  
DINARELLO CA, 1991, BLOOD, V77, P1627
[4]  
DINARELLO CA, 1993, NEW ENGL J MED, V328, P106
[5]   NEUTROPHIL ACTIVATION IN PREGNANCY-INDUCED HYPERTENSION [J].
GREER, IA ;
HADDAD, NG ;
DAWES, J ;
JOHNSTONE, FD ;
CALDER, AA .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (08) :978-982
[6]  
GREER IA, 1990, 7 P WORLD C HYP PREG, P276
[7]  
GREER IA, 1991, LANCET, V337, P228
[8]  
Klebanoff SJ., 1988, Inflammation: Basic Principles and Clinical Correlates, P391
[9]   DELETERIOUS EFFECTS OF OXYGEN RADICALS IN ISCHEMIA REPERFUSION - RESOLVED AND UNRESOLVED ISSUES [J].
KLONER, RA ;
PRZYKLENK, K ;
WHITTAKER, P .
CIRCULATION, 1989, 80 (05) :1115-1127
[10]   EXPRESSION OF INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST BY HUMAN RHEUMATOID SYNOVIAL TISSUE MACROPHAGES [J].
KOCH, AE ;
KUNKEL, SL ;
CHENSUE, SW ;
HAINES, GK ;
STRIETER, RM .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 65 (01) :23-29